ROBERT PEPRAH: Open Payments
NPI 1699794529 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$154 in 7 payments from 5 companies in 2025. Trend: 2023 $140 · 2024 $179 · 2025 $154
Food & beverage: $154
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $52 |
| E.R. Squibb & Sons, L.L.C. | 1 | $39 |
| ABBVIE INC. | 2 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: ARISTADA, COBENFY, VRAYLAR, INVEGA SUSTENNA, UZEDY.
Industry payments across NV — which companies pay providers there.
